HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Biology, treatment, and outcome in very young and older women with DCIS.

AbstractBACKGROUND:
This study examines a modern cohort of women with ductal carcinoma-in-situ (DCIS) in order to identify potential differences in clinical presentation, treatments, and outcome based on age.
METHODS:
From 1996 to 2009, a total of 2037 patients with pure DCIS were treated. Clinical presentation, pathologic factors, type of surgery and adjuvant therapy, and local recurrence rates among age groups were compared and analyzed. Median follow-up was 5.2 years.
RESULTS:
There were 132 patients (6.5 %) aged <40, 1,690 (83 %) aged 40-70, and 215 (10.5 %) aged >70. Younger patients (<40) were significantly more likely to have a family history of breast cancer, present with clinical symptoms, undergo mastectomy with immediate reconstruction, and have a contralateral prophylactic mastectomy (P < 0.05). Older patients (>70) were significantly less likely to use adjuvant radiotherapy and tamoxifen (P < 0.05). No significant differences were found in DCIS size, estrogen receptor status, necrosis, or contralateral breast cancer based on age. Among women <40, 29.3 % had evidence of multicentric disease versus 17.7 and 13.3 % in the women aged 40-70 and those >70, respectively (P = 0.004). On multivariate analysis, younger age (<40), larger-size DCIS (≥1.5 cm), and no use of radiotherapy were significant independent predictors of locoregional recurrence. The 5 year rates of local recurrence were 10.1 % in women <40 compared with 3.2 % in older women (P = 0.005).
CONCLUSIONS:
Younger patients with DCIS more often have multicentric disease, present with clinical findings, and opt for or require mastectomy with immediate reconstruction. Conservative surgery is only appropriate for younger patients if adjuvant radiotherapy is delivered.
AuthorsRosalinda Alvarado, Sara A Lari, Robert E Roses, Benjamin D Smith, Wei Yang, Elizabeth A Mittendorf, Banu K Arun, Anthony Lucci, Gildy V Babiera, Jamie L Wagner, Abigail S Caudle, Funda Meric-Bernstam, Rosa F Hwang, Isabelle Bedrosian, Kelly K Hunt, Henry M Kuerer
JournalAnnals of surgical oncology (Ann Surg Oncol) Vol. 19 Issue 12 Pg. 3777-84 (Nov 2012) ISSN: 1534-4681 [Electronic] United States
PMID22622473 (Publication Type: Clinical Trial, Journal Article, Research Support, N.I.H., Extramural)
Topics
  • Adult
  • Age Factors
  • Aged
  • Breast Neoplasms (mortality, pathology, surgery)
  • Carcinoma, Intraductal, Noninfiltrating (mortality, pathology, surgery)
  • Cohort Studies
  • Female
  • Follow-Up Studies
  • Humans
  • Middle Aged
  • Neoplasm Invasiveness
  • Neoplasm Recurrence, Local (mortality, pathology, surgery)
  • Neoplasm Staging
  • Prognosis
  • Survival Rate
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: